Course offering number:0808-503
Course ID:
2219
Topical Antiseptic Product Development
August 28, 2008 at 11:00 a.m. - 12:30 p.m. (EST–New York time)
90 Minute Accredited Online Training
Nava Dayan, Skin Care Research Expert
Dr. Nava Dayan earned her Ph.D. in Pharmaceutics from the
Hebrew University in Jerusalem specializing in skin delivery.
She is currently the R&D Director at Lipo Chemicals Inc. and
an Associate Adjunct Professor in the Ernest Mario School of
Pharmacy at Rutgers University. During her 20 years of
experience she has specialized in a variety of areas related to
skin treatment including:-
The research and understanding of the interaction between
topically applied compounds and the skin.
- Findings in skin biochemistry and especially the upper layer
of the skin- the stratum corneum
- Delivery of active compounds into and through the skin and
the development of delivery systems to facilitate transport,
improve bio-availability and reduce toxicity
- Design and development of topically applied formulations
- Design of clinical studies to substantiate market claims and
to assure safety
- Academic teaching and lecturing
- Industrial experience in both development of active
compounds, delivery systems and finished formulations
- Skin absorption studies in vivo and in vitro for safety/
efficacy assessment
- In vitro methodologies for safety assessment of topically
applied compounds
Dr. Dayan has received numerous awards of excellence for
various papers she has authored. She is the author and coauthor
of more then 80 publications. Dr. Dayan is a member
of the Dermatopharmaceutics Focus Group, and the Abstract
Review Committee for the American Association of
Pharmaceutical Scientists (AAPS), and the Consumer
Products Group of the International Controlled Release
Society (CRS). She is also a member of the US Society of
Cosmetic Chemists, and the chair of the Annual
Cosmeceuticals Summit Symposium. Dr. Dayan teaches at
Rutgers University and is the Director of several courses at
the Center for Professional Advancement.
|